FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: opalapril who wrote (60)	1/1/2001 3:13:25 PM
From: aknahow	of 75

Dear Mr. Opala Pril, By now I am sure you have seen that XOMA was the second best performing pick by S.I. members. The year 2001 will find XOMA involved in no less than four clinical trials. Psoriasis with anti-cd11a Kidney transplant with anti-cd11a Various types of cancer with ING-1 New indication for Neuprex. All of the other trials are underway and the new indication should begin this quarter. Perhaps XOMA now could be considered a lower risk situation? Institutional ownership is above 30% And even more important is the fact that Larry S-s like it a lot!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next